What is Sanofi India Ltd (SANOFI) share price today?

Sanofi India Ltd (SANOFI) is listed on the NSE. Visit VestAI at https://www.vestai.io/stocks/SANOFI for the latest live price, technical analysis, and AI-powered insights.

How to analyse SANOFI stock?

VestAI provides comprehensive SANOFI stock analysis including RSI, MACD, Bollinger Bands, SMA trend, ROCE, debt-to-equity ratio, and smart money holdings by superstar investors.

What sector is Sanofi India Ltd in?

Sanofi India Ltd (SANOFI) is in the Healthcare sector, Pharmaceuticals industry on the NSE.

Sanofi India Ltd

Q: What is Sanofi India Ltd's Orion Score?

Sanofi India Ltd has an Orion Score of 64/100 (Watch) — a fundamentals-based quality & risk score. Sanofi India Ltd scores 64/100 (Watch) on the Orion Score — strong business quality (85), poor growth (7), strong balance-sheet safety (94) and fair valuation (40). A fundamentals-based quality & risk score, not a buy/sell recommendation.

SANOFI

NSE· Healthcare

₹3,349.80

-52.10 (-1.53%)

Updated 09:16 am IST

52W Low · ₹3,085.2052W High · ₹6,044.50

Near 52W Low

Market Cap

₹7338.48L Cr

Volume

43.6K

Prev Close

₹3,356.00

ISIN

INE058A01010

Orion Score

Fundamentals-based quality & risk · not a recommendation

64/100

Watch

Sanofi India Ltd scores 64/100 (Watch) on the Orion Score — strong business quality (85), poor growth (7), strong balance-sheet safety (94) and fair valuation (40). A fundamentals-based quality & risk score, not a buy/sell recommendation.

Quality

Growth

Safety

Value

Full Orion analysis

Risk checks

Profit converts to cash (CFO 0.8× PAT)
Low debt, comfortable interest cover
No distress, manipulation or dilution flags

Forensic accounting

Piotroski F 4/9Altman Z Safe(9.03)Beneish M Elevated(-1.88)

Piotroski F = fundamental health (0–9, higher is better) · Altman Z = bankruptcy / distress risk · Beneish M = earnings-manipulation check

Technical / Momentum

Price Trend

45/100

Neutral

Technical momentum companion — separate from the fundamentals-based Orion Score.

Unlock with Pro

Upgrade →

VestAI Stock Score

VALUATION

Low Debt

D/E 0.02x — lean balance sheet

QUALITY

High Quality

ROCE 59.5% — excellent capital efficiency

MOMENTUM

Neutral

RSI 53.2 — consolidating

Price Chart

SMA 20

SMA 50

SMA 200

Key Fundamentals

Q4 FY2026

P/E Ratio: 23.70
ROCE: 59.47%
ROE (1Y): 47.10%
D/E Ratio: 0.02x
OPM: 28.33%
TTM EPS: ₹134.47
Dividend Yield: 753.00%
Qtrly Sales: ₹472.30 Cr
Qtrly Profit: ₹102.60 Cr

Technical Signals

Quarterly Results

Revenue & Profit in ₹ Crores

Revenue Net Profit

Quarter	Revenue	Net Profit	OPM	EPS
Q4 2026	₹472.3	₹102.6	28.3%	₹44.55
Q3 2026	₹419.8	₹61.7	19.3%	₹26.79
Q1 2026	₹406.3	₹69.5	21.1%	₹30.18
Q4 2025	₹535.9	₹119.5	30.3%	₹51.89
Q3 2025	₹514.9	₹91.3	21.1%	₹39.64

Annual P&L

Revenue & Profit in ₹ Crores (Yearly)

Revenue Net Profit

Year	Revenue	Net Profit	EBITDA	OPM
FY 2025	₹1,823.4	₹326.7	₹483.7	24.9%
FY 2024	₹1,989	₹413.5	₹471.1	22.8%
FY 2023	₹1,981.6	₹602.9	₹569.8	22.9%
FY 2022	₹2,727.2	₹620.6	₹907.9	24.4%

Peer Comparison — Healthcare

Top companies in the same sector by market cap

Company	Mkt Cap	P/E	ROCE	ROE	D/E	OPM
SANOFI ★	₹7,338 Cr	23.70	59.47%	47.10%	0.02x	28.33%
SUNPHARMASun Pharmaceutical Industries	₹4,27,609 Cr	37.32	15.73%	14.72%	0.06x	18.90%
MAXHEALTHMax Healthcare Institute	₹95,110 Cr	66.21	11.94%	14.33%	0.32x	22.56%
AUROPHARMAAurobindo Pharma Limited	₹90,029 Cr	25.94	12.55%	9.93%	0.21x	15.11%
ABBOTINDIAAbbott India Limited	₹57,724 Cr	36.63	36.14%	34.46%	0.04x	27.01%
AJANTPHARMAjanta Pharma Limited	₹41,836 Cr	39.55	27.99%	25.39%	0.06x	51.40%

Balance Sheet

All values in ₹ Crores

Metric	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	₹1,254.8	₹1,611.8	₹1,714.8	₹2,071.7
Equity	₹749.2	₹860.6	₹1,015.2	₹1,275.8
Total Debt	₹17.8	₹19.3	₹19	₹23.6
Cash	₹262.9	₹283.8	₹394.5	₹1,004.9
Net Debt	—	—	—	—
Working Capital	₹309.2	₹407.6	₹596.7	₹869.7

Shareholding Pattern

Q1 FY2027

Promoter

60.6%

FII

13.42%

DII

10.98%

Public

15%

Quarter-over-Quarter Trend

Quarter	Promoter	FII	DII	Public
Q1 FY2027	60.6% ↑	13.42% ↑	10.98% ↓	15% ↑
Q3 FY2026	60.4%	5.55% ↓	21.3% ↓	12.75% ↑
Q2 FY2026	60.4%	5.57% ↓	22.28% ↓	11.75% ↑
Q1 FY2026	60.4%	5.61% ↑	23.06% ↑	10.94% ↓
Q4 FY2025	60.4%	5.58% ↓	23.02% ↑	11.01% ↓
Q3 FY2025	60.4%	5.64% ↓	22.94% ↑	11.04% ↓
Q2 FY2025	60.4%	5.78% ↓	22.62% ↑	11.2% ↓
Q1 FY2025	60.4%	5.81%	22.6%	11.21%

Corporate Actions

Ex-Date	Action	Details
2026-04-22	DIVIDEND	Dividend - Rs 48 Per Share

Smart Money Holdings

Q3 FY2025

Investor	Shares Held	Portfolio %	Change
Dolly Khanna	1,20,000	18.24%	—
Dolly Khanna	1,20,000	18.14%	—
Dolly Khanna	1,20,000	18.12%	—
Dolly Khanna	2,30,000	12.32%	—

Funds Holding This Stock

20 mutual fund schemes

Tata India Pharma & Healthcare Fund Direct GrowthTATA

1.46%

₹20 Cr

Bandhan Healthcare Fund Direct GrowthIDFC

1.20%

₹4 Cr

Abakkus Small Cap Fund Direct GrowthAbakkus

1.11%

₹12 Cr

Nippon India Pharma Fund Direct GrowthRELIANCE

0.83%

₹72 Cr

Nippon India Innovation Fund Direct GrowthRELIANCE

0.54%

₹15 Cr

Aditya Birla Sun Life MNC Fund Direct GrowthBIRLA_SUN_LIFE

0.44%

₹14 Cr

Sundaram Dividend Yield Fund Direct GrowthSUNDARAM

0.43%

₹4 Cr

Aditya Birla Sun Life Dividend Yield Fund Direct GrowthBIRLA_SUN_LIFE

0.41%

₹6 Cr

Aditya Birla Sun Life Consumption Direct Fund GrowthBIRLA_SUN_LIFE

0.40%

₹23 Cr

Aditya Birla Sun Life Balanced Advantage Fund Direct GrowthBIRLA_SUN_LIFE

0.33%

₹30 Cr

Analyse SANOFI with Orion AI

Ask: "Is Sanofi India Ltd stock a good buy right now?" — Get RSI, MACD, ROCE + AI recommendation

Analyse with Orion

Want more insights like this?

Get free stock analysis, market insights, and investment ideas delivered to your inbox.

No spam. Unsubscribe anytime.

About Sanofi India Ltd (SANOFI) Stock

Sanofi India Ltd is listed on the NSE under the Healthcare sector, Pharmaceuticals industry. ISIN: INE058A01010. Track live share price, technical analysis, RSI, MACD, PE ratio, and smart money holdings on VestAI — India's AI-powered stock analysis platform.